Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Decock

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|July 1, 2021
Transcription Factors: The Fulcrum Between Cell Development and CarcinogenesisZeyaul Islam, Ameena Mohamed Ali, Adviti Naik, et al.
Journal of Translational Medicine|January 4, 2019
PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancerGhaneya Al-Khadairi, Adviti Naik, Remy Thomas, et al.
Plos One|March 8, 2013
TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2Suvi-Katri Leivonen, Konstantinos Lazaridis, Julie Decock, et al.
Frontiers in Immunology|May 18, 2018
NY-ESO-1 Based Immunotherapy of Cancer: Current PerspectivesRemy Thomas, Ghaneya Al-Khadairi, Jessica Roelands, et al.
Breast Cancer Research : BCR|April 8, 2015
Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic miceJulie Decock, Wouter Hendrickx, Sally Thirkettle, et al.
The Journal of Biological Chemistry|May 2, 2013
Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cellsSally Thirkettle, Julie Decock, Hugh Arnold, et al.
NPJ Breast Cancer|March 19, 2026
Comprehensive genomic analysis of non-BRCA familial breast cancer in an Arab populationEhsan Ullah, Hikmat Abdel-Razeq, Sana Bentebbal, et al.
Cancers|July 13, 2024
The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell SurvivalAdviti Naik, Remy Thomas, Martin Sikhondze, et al.
Mutation Research|April 21, 2007
Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriersSylvia De Brakeleer, Marika Bogdani, Jacques De Grève, et al.
Pharmaceutics|January 28, 2026
Cell-Penetrating Peptide-Mediated siRNA Targeting of LDHC Suppresses Tumor Growth in a Triple-Negative Breast Cancer Zebrafish Xenograft ModelHanan Qasem, Adviti Naik, Tricia Gomez, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|July 1, 2021
Transcription Factors: The Fulcrum Between Cell Development and CarcinogenesisZeyaul Islam, Ameena Mohamed Ali, Adviti Naik, et al.
Journal of Translational Medicine|January 4, 2019
PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancerGhaneya Al-Khadairi, Adviti Naik, Remy Thomas, et al.
Plos One|March 8, 2013
TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2Suvi-Katri Leivonen, Konstantinos Lazaridis, Julie Decock, et al.
Frontiers in Immunology|May 18, 2018
NY-ESO-1 Based Immunotherapy of Cancer: Current PerspectivesRemy Thomas, Ghaneya Al-Khadairi, Jessica Roelands, et al.
Breast Cancer Research : BCR|April 8, 2015
Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic miceJulie Decock, Wouter Hendrickx, Sally Thirkettle, et al.
The Journal of Biological Chemistry|May 2, 2013
Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cellsSally Thirkettle, Julie Decock, Hugh Arnold, et al.
NPJ Breast Cancer|March 19, 2026
Comprehensive genomic analysis of non-BRCA familial breast cancer in an Arab populationEhsan Ullah, Hikmat Abdel-Razeq, Sana Bentebbal, et al.
Cancers|July 13, 2024
The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell SurvivalAdviti Naik, Remy Thomas, Martin Sikhondze, et al.
Mutation Research|April 21, 2007
Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriersSylvia De Brakeleer, Marika Bogdani, Jacques De Grève, et al.
Pharmaceutics|January 28, 2026
Cell-Penetrating Peptide-Mediated siRNA Targeting of LDHC Suppresses Tumor Growth in a Triple-Negative Breast Cancer Zebrafish Xenograft ModelHanan Qasem, Adviti Naik, Tricia Gomez, et al.
Pageof 6